Tong Lu
Tong Lu
"Genentech", "University of Southern California", "Shanghai Institute of Materia Medica"
Verified email at
Cited by
Cited by
Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats
H Liu, J Yang, F Du, X Gao, X Ma, Y Huang, F Xu, W Niu, F Wang, Y Mao, ...
Drug Metabolism and Disposition 37 (12), 2290-2298, 2009
Pharmacokinetics of ranibizumab in patients with neovascular age-related macular degeneration: a population approach
L Xu, T Lu, L Tuomi, N Jumbe, J Lu, S Eppler, P Kuebler, ...
Investigative ophthalmology & visual science 54 (3), 1616-1624, 2013
Comparative pharmacokinetics of baicalin after oral administration of pure baicalin,< i> Radix scutellariae</i> extract and Huang-Lian-Jie-Du-Tang to rats
T Lu, J Song, F Huang, Y Deng, L Xie, G Wang, X Liu
Journal of ethnopharmacology 110 (3), 412-418, 2007
Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine
T Lu, J Yang, X Gao, P Chen, F Du, Y Sun, F Wang, F Xu, H Shang, ...
Drug Metabolism and Disposition 36 (8), 1578-1586, 2008
Simultaneous determination of berberine and palmatine in rat plasma by HPLC–ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du …
T Lu, Y Liang, J Song, L Xie, GJ Wang, XD Liu
Journal of pharmaceutical and biomedical analysis 40 (5), 1218-1224, 2006
Minimal residual disease dynamics after venetoclax-obinutuzumab treatment: extended off-treatment follow-up from the randomized CLL14 study
O Al-Sawaf, C Zhang, T Lu, MZ Liao, A Panchal, S Robrecht, T Ching, ...
Journal of Clinical Oncology 39 (36), 4049, 2021
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
JF Seymour, TJ Kipps, BF Eichhorst, J D’Rozario, CJ Owen, S Assouline, ...
Blood, The Journal of the American Society of Hematology 140 (8), 839-850, 2022
A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities
D Lu, T Lu, M Stroh, RA Graham, P Agarwal, L Musib, CC Li, BL Lum, ...
Cancer chemotherapy and pharmacology 77, 459-476, 2016
‘LC‐electrolyte effects’ improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery
L Wang, Y Sun, F Du, W Niu, T Lu, J Kan, F Xu, K Yuan, T Qin, C Liu, C Li
Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2007
Pharmacokintics of the Ginkgo Bfollowing intravenous administration of Ginkgo B emulsion in rats
WD Chen, Y Liang, L Xie, T Lu, XD Liu, GJ Wang
Biological and Pharmaceutical Bulletin 30 (1), 1-5, 2007
Integrated two‐analyte population pharmacokinetic model of polatuzumab vedotin in patients with non‐Hodgkin lymphoma
D Lu, T Lu, L Gibiansky, X Li, C Li, P Agarwal, CS Shemesh, R Shi, ...
CPT: Pharmacometrics & Systems Pharmacology 9 (1), 48-59, 2020
High‐performance liquid chromatographic method for the determination and pharmacokinetic study of wogonoside in rat serum after oral administration of traditional Chinese …
YX Deng, T Lu, L Xie, XD Liu
Biomedical Chromatography 20 (10), 1098-1102, 2006
Development of a physiologically based pharmacokinetic model for itraconazole pharmacokinetics and drug–drug interaction prediction
Y Chen, F Ma, T Lu, N Budha, JY Jin, JR Kenny, H Wong, CECA Hop, ...
Clinical pharmacokinetics 55, 735-749, 2016
Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma
T Lu, L Gibiansky, X Li, C Li, R Shi, P Agarwal, J Hirata, D Miles, P Chanu, ...
Leukemia & Lymphoma 61 (12), 2905-2914, 2020
Simple, sensitive and rapid liquid chromatography/atmospheric pressure chemical ionization mass spectrometric method for the quantitation of Ranolazine in rat plasma
Y Liang, L Xie, XD Liu, WD Chen, T Lu, Y Xiong, GJ Wang
Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2006
Determination of limonin in rat plasma by liquid chromatography–electrospray mass spectrometry
Y Liang, L Xie, XD Liu, T Lu, GJ Wang, YZ Hu
Journal of pharmaceutical and biomedical analysis 39 (5), 1031-1035, 2005
黄芩苷及其含药血清在大鼠体内的药动学, 药效学相关性研究
宋珏, 路通, 谢林, 王广基, 刘晓东
中国临床药理学与治疗学 11 (12), 1350, 2006
Semi‐mechanism‐based population pharmacokinetic modeling of the Hedgehog pathway inhibitor vismodegib
T Lu, B Wang, Y Gao, M Dresser, RA Graham, JY Jin
CPT: Pharmacometrics & Systems Pharmacology 4 (11), 680-689, 2015
Gender difference in ranolazine pharmacokinetics in rats
XD Liu, L Xie, Y Liang, L Li, T Lu
European journal of drug metabolism and pharmacokinetics 28, 119-123, 2003
Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphoma
CS Shemesh, P Agarwal, T Lu, C Lee, RC Dere, X Li, C Li, JY Jin, S Girish, ...
Cancer chemotherapy and pharmacology 85, 831-842, 2020
The system can't perform the operation now. Try again later.
Articles 1–20